(-0.57%) 5 078.50 points
(-0.39%) 38 530 points
(-0.86%) 17 512 points
(0.04%) $82.84
(0.00%) $1.653
(0.00%) $2 338.50
(0.14%) $27.39
(-0.01%) $915.70
(-0.23%) $0.932
(-0.27%) $10.95
(-0.40%) $0.799
(-0.24%) $92.10
Quarter results today
(bmo 2024-04-25)
Expected move: +/- 4.87%
Live Chart Being Loaded With Signals
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions...
Stats | |
---|---|
Today's Volume | 793 521 |
Average Volume | 750 372 |
Market Cap | 17.49B |
EPS | $0 ( 2024-04-23 ) |
Last Dividend | $0.720 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 48.02 |
ATR14 | $0.0960 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Eisenberg Glenn A | Buy | 10 229 | Common Stock |
2024-04-15 | Eisenberg Glenn A | Sell | 4 496 | Common Stock |
2024-04-15 | Eisenberg Glenn A | Sell | 10 229 | Restricted Stock Unit |
2024-04-01 | Schroeder Mark S | Sell | 6 477 | Common Stock |
2024-04-01 | Summy Amy B. | Sell | 3 500 | Common Stock |
INSIDER POWER |
---|
-9.85 |
Last 100 transactions |
Buy: 251 595 | Sell: 302 098 |
Volume Correlation
Laboratory Corporation of Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Laboratory Corporation of Correlation - Currency/Commodity
Laboratory Corporation of Financials
Annual | 2023 |
Revenue: | $12.16B |
Gross Profit: | $3.15B (25.86 %) |
EPS: | $4.80 |
Q3 | 2023 |
Revenue: | $3.03B |
Gross Profit: | $762.20M (25.13 %) |
EPS: | $-1.970 |
Q2 | 2023 |
Revenue: | $3.06B |
Gross Profit: | $851.20M (27.85 %) |
EPS: | $2.12 |
Q1 | 2023 |
Revenue: | $3.03B |
Gross Profit: | $842.20M (27.76 %) |
EPS: | $2.13 |
Financial Reports:
No articles found.
Laboratory Corporation of Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 1990-12-31 |
Last Dividend | $0.720 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-12 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | $7.64 | -- |
Avg. Dividend % Per Year | 0.54% | -- |
Score | 3.12 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.03 | |
Div. Directional Score | 8.30 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.150 | 0.61% |
1991 | $0.500 | 2.19% |
1992 | $0.950 | 1.59% |
1993 | $0.800 | 2.11% |
1994 | $0.200 | 0.65% |
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $2.16 | 0.84% |
2023 | $2.88 | 1.41% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0324 | 1.500 | 9.35 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0250 | 1.200 | 9.17 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0480 | 1.500 | -0.578 | -0.867 | [0.1 - 1] |
payoutRatioTTM | 0.608 | -1.000 | 3.92 | -3.92 | [0 - 1] |
currentRatioTTM | 1.167 | 0.800 | 9.16 | 7.33 | [1 - 3] |
quickRatioTTM | 0.817 | 0.800 | 9.90 | 7.92 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.186 | -0.280 | [0.2 - 2] |
debtRatioTTM | 0.313 | -1.500 | 4.79 | -7.19 | [0 - 0.6] |
interestCoverageTTM | 5.46 | 1.000 | 9.09 | 9.09 | [3 - 30] |
operatingCashFlowPerShareTTM | 15.64 | 2.00 | 4.79 | 9.57 | [0 - 30] |
freeCashFlowPerShareTTM | 10.12 | 2.00 | 4.94 | 9.88 | [0 - 20] |
debtEquityRatioTTM | 0.664 | -1.500 | 7.35 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.266 | 1.000 | 8.90 | 8.90 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0844 | 1.000 | -0.312 | -0.312 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.254 | 1.000 | 9.70 | 9.70 | [0.2 - 2] |
assetTurnoverTTM | 0.771 | 0.800 | 8.19 | 6.55 | [0.5 - 2] |
Total Score | 10.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.23 | 1.000 | 5.83 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0480 | 2.50 | -0.372 | -0.867 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.12 | 2.00 | 6.63 | 9.88 | [0 - 30] |
dividendYielPercentageTTM | 1.385 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 15.64 | 2.00 | 4.79 | 9.57 | [0 - 30] |
payoutRatioTTM | 0.608 | 1.500 | 3.92 | -3.92 | [0 - 1] |
pegRatioTTM | 2.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.103 | 1.000 | 9.93 | 0 | [0.1 - 0.5] |
Total Score | 6.03 |
Laboratory Corporation of
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators